Valuation: Fisher & Paykel Healthcare Corporation Limited

Capitalization 20.97B 12.02B 11.44B 10.79B 9.53B 17.03B 1,041B 18.9B 129B 47.61B 435B 45.06B 44.16B 1,828B P/E ratio 2025 *
58.1x
P/E ratio 2026 * 48.5x
Enterprise value 20.87B 11.96B 11.39B 10.74B 9.48B 16.95B 1,036B 18.8B 128B 47.37B 433B 44.84B 43.93B 1,819B EV / Sales 2025 *
10.4x
EV / Sales 2026 * 9.18x
Free-Float
-
Yield 2025 *
1.23%
Yield 2026 * 1.38%
More valuation ratios * Estimated data
Dynamic Chart

Last Transcript: Fisher & Paykel Healthcare Corporation Limited

1 day+1.94%
1 week+3.41%
Current month-4.84%
1 month-4.71%
3 months-3.82%
6 months+10.60%
Current year-6.82%
More quotes
1 week
34.50
Extreme 34.5
35.80
1 month
34.36
Extreme 34.36
39.50
Current year
34.36
Extreme 34.36
39.50
1 year
23.50
Extreme 23.5
39.50
3 years
18.02
Extreme 18.02
39.50
5 years
18.02
Extreme 18.02
39.50
10 years
6.10
Extreme 6.1
39.50
More quotes
Director TitleAgeSince
Chief Executive Officer 64 2016-03-31
Director of Finance/CFO - 2019-02-28
Chief Tech/Sci/R&D Officer - 2014-07-31
Manager TitleAgeSince
Director/Board Member 67 2001-10-31
Director/Board Member 64 2016-03-31
Director/Board Member - 2017-05-31
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
+1.94%+3.41%+50.65%+23.17% 12.02B
-0.90%+1.19%+14.93%+5.35% 227B
+0.66%+3.11%+9.55%-10.68% 119B
-0.09%-2.20%-6.32%-17.09% 64.55B
-0.55%-2.12%+4.10%+71.49% 47.05B
-1.41%+2.26%+5.74%+25.46% 43.77B
+5.92%+1.12%-24.32%-14.67% 34.8B
-1.58%-1.03%+2.66%+46.63% 27.11B
-1.40%-0.24%-12.41%-40.12% 21.57B
+0.05%-1.74%-5.88%-5.60% 21.55B
Average +0.26%+0.25%+3.87%+8.39% 61.8B
Weighted average by Cap. -0.10%+0.80%+6.47%+5.44%
See all sector performances

Financials

2025 *2026 *
Net sales 2.01B 1.15B 1.1B 1.03B 912M 1.63B 99.64B 1.81B 12.3B 4.56B 41.67B 4.31B 4.23B 175B 2.27B 1.3B 1.24B 1.17B 1.03B 1.84B 113B 2.05B 13.92B 5.16B 47.17B 4.88B 4.78B 198B
Net income 359M 206M 196M 185M 163M 292M 17.85B 324M 2.2B 816M 7.46B 772M 757M 31.34B 428M 246M 234M 221M 195M 348M 21.27B 386M 2.63B 973M 8.9B 921M 902M 37.34B
Net Debt -106M -60.78M -57.86M -54.57M -48.2M -86.11M -5.27B -95.56M -650M -241M -2.2B -228M -223M -9.24B -118M -67.54M -64.3M -60.64M -53.56M -95.69M -5.85B -106M -722M -268M -2.45B -253M -248M -10.27B
More financial data * Estimated data
Logo Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets products and systems for use in acute and chronic respiratory care, surgery, and the treatment of obstructive sleep apnea. The Company provides medical device products and systems for use in both hospital and homecare settings. Its hospital product group includes products used in invasive ventilation, noninvasive ventilation, nasal high flow therapy, anesthesia, and laparoscopic and open surgery. Its homecare product group includes devices and systems used to treat obstructive sleep apnea (OSA) and provide respiratory support in the home, which include its continuous positive airway pressure (CPAP) therapy masks as well as flow generators, interfaces, and data management technologies. The Company’s products are sold in over 120 countries worldwide. It operates across Canada, the United States of America, Mexico, Costa Rica, the United Kingdom, Switzerland, India, and others.
Employees
7,005
More about the company
Date Price Change Volume
25-02-14 35.78 $ +1.94% 185,475
25-02-13 35.10 $ -0.03% 313,107
25-02-12 35.11 $ +0.03% 497,070
25-02-11 35.10 $ +0.26% 256,163
25-02-10 35.01 $ -0.40% 267,058

End-of-day quote New Zealand S.E., February 13, 2025

More quotes
Trading Rating
Investor Rating
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
11
Last Close Price
35.78NZD
Average target price
34.38NZD
Spread / Average Target
-3.92%
Consensus

Quarterly revenue - Rate of surprise